Evidence map›Paper›PMID 38074478›Full record

ArticleIranian journal of otorhinolaryngology2023

Sinonasal Neuroendocrine Carcinoma in Adult Proteus Syndrome.

Giorgos Sideris, Thomas Nikolopoulos, Antigone Sourla, Penelope Korkolopoulou, Pavlos Papadakis, Alexander Delides

Open access · greenAbstract readCase Reports
In one paragraph

Article in Iranian journal of otorhinolaryngology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.6field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 2 citations in OpenAlex.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Giorgos SiderisSecond ΕΝΤ Department, School of Medicine, "Attikon" University Hospital, National & Kapodistrian University of Athens, Athens, Greece.
Thomas NikolopoulosSecond ΕΝΤ Department, School of Medicine, "Attikon" University Hospital, National & Kapodistrian University of Athens, Athens, Greece.
Antigone SourlaFirst Department of Pathology, School of Medicine, National & Kapodistrian University of Athens, Athens, Greece.
Penelope KorkolopoulouFirst Department of Pathology, School of Medicine, National & Kapodistrian University of Athens, Athens, Greece.
Pavlos PapadakisFirst Department of Pathology, School of Medicine, National & Kapodistrian University of Athens, Athens, Greece.
Alexander DelidesSecond ΕΝΤ Department, School of Medicine, "Attikon" University Hospital, National & Kapodistrian University of Athens, Athens, Greece.
National and Kapodistrian University of Athens · GR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: Proteus syndrome (PS) is a rare genetic disorder usually caused by mutations in AKT1 or PTEN genes, characterized by multiple, asymmetric tissue overgrowth with high clinical variability. Sinonasal neuroendocrine carcinomas (SNEC) are exceptionally rare tumors encountered in the ethmoid sinus, nasal cavity, or maxillary sinus. Case Report: We report a 35-year-old patient with PS, who underwent successful surgical removal of a well-differentiated SNEC obstructing his nasal cavity and highlight the role of the otolaryngologist for safe airway management, minimal surgical intervention and coordination of the multidisciplinary care. Histologically, focally hyperplastic mucosal epithelium of respiratory type of the nasal chamber was noticed along with seromucinous glands and capillary congestion of the subepithelial fibrovascular tissue. The limited presence of neoplastic tissue with histomorphological and immunophenotypic features of a neuroendocrine neoplasm was focally observed. Tumor cells grow in the form of islets within a vascular stroma; these neoplastic cells are immunohistochemically positive for synaptophysin, CD56, EMA, Ki67 (low expression, cell proliferation rate: 2%), CD31, chromogranin and pancytokeratin AE1 / AE3 as well as for S-100 protein (weak intensity). Conclusions: This first description of a SNEC in a PS patient, might hint towards a common basis between the two conditions, due to the mosaic AKT1 variant and an activated AKT/PIK3CA/PTEN pathway.

Indexed as

OtolaryngologyProteus SyndromePTEN hamartoma tumor SyndromeSinonasal neuroendocrine carcinomaTypical carcinoid

Identifiers

PMID38074478
PMCPMC10701243
OpenAlexW4389800725

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.